(f) in anti-bacterial tablets containing 2.5 g or 60 less of sodium dichloroisocyanurate..
(g) in other compressed blocks or tablets containing 10,22,23 12,13,14,15, 10 per cent or more of available chlorine except 17,18,19,21 in preparations containing 21 g or less of sodium
dichloroisocyanurate for use in toilet cisterns only.
(h) in other compressed blocks or tablets containing 10,22 12,13,14,15,17,
10 per cent or more of available chlorine 18,19,21
certified by a relevant State or Territory authority
as not being a Dangerous Good of Class 5,
Division 5.1: Oxidising substances, as specified
in the Australian Code for the Transport of
Dangerous Goods by Road and Rail except in
preparations containing 21 g less of sodium
dichloroisocyanurate for use in toilet cisterns only.
(i) in other compressed blocks or tablets containing
10 per cent or more of available chlorine in
preparations containing 5 g or less of sodium
dichloroisocyanurate for use in toilet bowls only:
(i) during storage 10,22,23 12,13,14,15,17,
18,21
(ii) during use 5 1,4,7,12
(j) in other compressed blocks or tablets containing
10 per cent or more of available chlorine certified
by a relevant State or Territory authority as not
being a Dangerous Good of Class 5, Division 5.1:
Oxidising substances, as specified in the
Australian Code for the Transport of Dangerous
Goods by Road and Rail in preparations
containing 5 g or less of sodium dichloroisocyanurate
for use in toilet bowls only.
(i) during storage 10,22 12,13,14,15,17,
18,21
(ii) during use 5 1,4,7,12
Dichloromethane (methylene chloride)
(a) in paint or lacquer removers. 12,16 1,4,8,11
(b) other than in paint or lacquer removers 1,4,8,25
Diclofenac 101,104
Dienestrol 67
Diethanolamine when included in Schedule 5. 5 1,4
Diethanolamine when included in Schedule 6. 2,11,18 1,4,8
Diethyltoluamide for human use. 44
5,6-Dihydroxyindoline 21,28
Dimethylformamide 1,4,8
Dimethyl sulfate 2 1,4,8
Dimethyl sulfoxide
(a) when not packed and labelled for therapeutic use. 27 1,4,5,8
(b) when packed and labelled for treatment of animals. 49 1,4,5,8
Dinitrocresols (and their homologues) except when for 1,4,8
therapeutic use.
Dinitrophenols (and their homologues) except when 1,4,8
for therapeutic use.
Dinocap 47
Dioxane 1,4,8
Diphenoxylate when included in Schedule 3. 39 or 40,41
Econazole in vaginal preparations when included 54,63,64,66
Ephedrine in nasal preparations for topical use. 29
Epichlorohydrin 2 1,4,8
Epoxy resins, liquid. 1,3,4,5,8
Ethanolamine when included in Schedule 5. 5 1,4
Ethanolamine when included in Schedule 6. 2,11,18 1,4,8
Ether when included in Schedule 5 or 6. 1,4,8
Ethoxyethylmercuric chloride 1,4
Ethyl bromide 1,4,8
Ethylene chlorohydrin 1,4,8
Ethylene glycol monoalkyl ethers and their acetates 1,4,8
except when separately specified.
Ethylene oxide 1,4,8
Ethylmercuric chloride 1,4
Ethyl methacrylate 28 4,9,23
Etretinate 7,62,76
Eugenol 1
Famotidine when included in Schedule 2. 96
Fenoterol in metered aerosols. 32
Fluconazole in oral preparations when included in 64 Schedule 3.
Fluorides (including silicofluorides) when included in 1,4
Schedule 5 or 6 except when separately specified.
Formaldehyde
(a) in nail hardener cosmetics. 106 1,4,8,36
(b) in other preparations. 106 1,4,8
Formic acid 1,4,8
Furfural 5 1,4
Glazing preparations containing lead compounds.. 50
Glutaraldehyde except when in Schedule 2
(a) 25 per cent or less. 5,59 1,4,5
(b) more than 25 per cent. 3,59 1,4,5,8
Glycolic acid 79 1,5,6,31
Hexachlorophane in preparations for skin cleansing 24
purposes containing 3 per cent or less of
hexachlorophane.
Hexyloxyethanol 2 1,4,8
Hydrazine 1,4,8
Hydrochloric acid
(a) 30 per cent or less of HCl. 1,4
(b) more than 30 per cent of HCl. 1,4,8
Hydrocortisone
(a) for dermal use when included in 38,72,73,74,75
Schedule 2 or 3.
(b) for topical rectal use when includeed 38,75
in Schedule 2 or 3.
Hydrocyanic acid when included in Schedule 7. 13 4,8
Hydrofluoric acid (including mixtures that generate
hydrofluoric acid)
Hydrogen peroxide
(a) more than 3 per cent up to 10 per cent. 5 1
(b) more than 10 per cent up to 20 per cent. 5 2
(c) more than 20 per cent. 2 2,4
Hydroquinone
(a) when in Schedule 2. 45
(b) except when in Schedule 2 or 4. 1,4
Hydrosilicofluoric acid (including mixtures
that generate hydrosilicofluoric acid)
8-Hydroxyquinoline (including salts and 33
derivatives) when prepared for
internal use.
Ibuprofen 101,104
Iodine
(a) more than 20 per cent. 1,4,8
(b) in preparations for human internal therapeutic 91,92 use containing 300 micrograms or more of
iodine per recommended daily dose.
Ipratropium bromide in metered aerosols. 32
Isocyanates (free organic)
(a) when in paint. 28,52 1,5,8,10,27
(b) other than in paint. 28,52 1,4,8
Isoprenaline in metered aerosols 32
Isotretinoin
(a) for human oral use. 7,62,76
Lead compounds
(a) in hair cosmetics. 25
(b) when in Schedule 6. 1,4,8
Leflunomide 7,62,87
Lemon oil 89
Lenalidomide 7,62,76
Levocabastine
(a) in eye or nasal preparations containing 62
0.5 mg/mL or less of levocabastine.
(b) in other preparations. 62 and
either 39 or 40
Lime oil 89
Loperamide when in Schedule 2. 41
Magnesium chlorate 1,4
Mefenamic acid 101,104
Mercuric thiocyanate 1,4
Metacresolsulphonic acid and formaldehyde 1,4
condensation product for the treatment of animals.
Methanol except in methylated spirit. 1,4,8
Methoxamine in nasal preparations for topical use. 29
Methyl chloride 1,4,8
Methyl ethyl ketone 5 1,4,8
Methyl ethyl ketone oxime 5,28 1,4
Methyl ethyl ketone peroxide 2 2,3,4,6
Methyl iso-amyl ketone 1,4,8
Methyl iso-butyl ketone 1,4,8
Methyl iso-thiocyanate 5,12 1,4,8
Methyl methacrylate 28 4,9,23
Methyldibromo glutaronitrile 28 1,4,7
Methylene bisthiocyanate 1,4
Methyleugenol 1,6
Methylnorbornylpyridine 59
1-(beta-Methyl sulphonamidoethyl)- 2-amino-3-
N,N-diethylaminobenzene 1,4,8
Miconazole in vaginal preparations when included 54,63,64,66
Misoprostol 53
Naphazoline in nasal preparations for topical use. 29
Naphthalene
(a) in block, ball, disc, pellet or flake form, 9,105
enclosed in a device which, in normal
use, prevents removal or ingestion of its
contents.
(b) in other forms. 9,105 1
Naproxen 101,104
Nicotine except when in tobacco or when included 1,4 in Schedule 2.
Nitric acid
(a) 75 per cent or less HNO3. 2 1,4
(b) more than 75 per cent HNO3. 2 1,4,8
Nitrobenzene 1,4,8
Nitrophenols 1,4
Nitroprussides in aerosols. 84 8
Nizatidine when included in Schedule 2. 96
Noradrenaline in metered aerosols. 32
Nystatin in vaginal preparations when included 54,63,64,65,66
Orange oil (bitter) 89
Orciprenaline in metered aerosols. 32
Oxalates, metallic 4,8
Oxalic acid 2 4,8
Oxymetazoline in nasal preparations for topical use. 29
Paint
(a) First Schedule paints. 83
(b) Second Schedule paints. 84
Paracetamol 97 and/or 98,99,100
Pentachlorophenol 1,4,8
Peracetic acid 2 1,4,8
Permanganates 2 24
2-Phenoxyethanol 5 1
Phenol and any other homologue of phenol. 1,4
Phenols 5
Phenylenediamines and alkylated phenylenediamines
(a) in hair dyes. 21
(b) in preparations other than hair dyes. 1,4,8
Phenylephrine in nasal preparations 29
for topical use.
N,N-bis(phenylmethylene)-bicyclo-
(2.2.1)heptane-2,5-dimethanamine 5,28 1,4,5,10
N,N-bis(phenylmethylene)-bicyclo-
(2.2.1)heptane-2,6-dimethanamine 5,28 1,4,5,10
ortho-Phenylphenol except when in 1,4
antiseptics.
Phenylpropanolamine 56
Phenytoin in pastes for the treatment of horses. 9
Phosphonic acid 1,4
Phosphoric acid 1,4
Phosphorus (yellow) 2 1,4
ortho-Phthalaldehyde
(a) when included in Schedule 5. 51,52,59 1,4,5,8,10
(b) when included in Schedule 6. 51,52,59 2,4,5,8,10
(a) in preparations containing 5 1,4,6 0.5 per cent or less of potassium
hydroxide.
(b) in solid preparations containing 2,10,78 3,5,28
more than 0.5 per cent of potassium hydroxide.
(c) in liquid preparations containing 2,10,78 3,5 more than 0.5 per cent of potassium hydroxide.
Potassium metabisulphite 5,26 1,4
Potassium nitrite in pickling or curing salts. 94
Potassium persulfate 5,21,25 1,5,23,33,34
Potassium sulfide 2 1,4
Propionic acid when in Schedule 6. 2 1,4
Ranitidine when included in Schedule 2. 96
Safrole
(a) in preparations for therapeutic use. 1
(b) other than for therapeutic use. 1,4
Salbutamol in metered aerosols or in dry 32 powder formulations.
Salicylamide 34 or 35
Sassafras oil
(a) in preparations for therapeutic use. 1
(b) other than for therapeutic use. 1,4
Selenium compounds except when for 1,4,8
therapeutic use (human or animal).
Silver in smoking deterrents. 42
Sitaxentan 7, 62, 76
Sodium aluminate 2 1,4
Sodium chlorate 1,4
Sodium dodecylbenzene sulfonate 79 1
Sodium fluoride in preparations for 43
human ingestion when in Schedule 2.
Sodium hydrogen sulfate 1,4,8
Sodium hydrosulfite 5,26 1,4,8
(more than 50 per cent)
Sodium hydroxide
(a) in preparations containing 0.5 per cent 5 1,4,6 or less of sodium hydroxide.
(b) in solid preparations containing more than 2,10,78 3,5,28 0.5 per cent of sodium hydroxide.
(c) in liquid preparations containing more than 2,10,78 3,5 0.5 per cent of sodium hydroxide.
Sodium laureth-6 carboxylate 79 1
Sodium metabisulphite 5,26 1,4
(more than 50 per cent)
Sodium nitrite in pickling or curing salts 94
Sodium persulfate 5,21,25 1,5,23,33,34
Sodium sulfide 2 1,4
Styrene 1,4,8
Sulfamic acid 2 1,4
Sulfuric acid 2 1,4
Symphytum spp. (Comfrey) when included in Schedule 5. 31,32
Tazarotene for topical use. 77,62
Terbutaline in metered aerosols or in dry powder formulations. 32
Terfenadine 61
Teriflunomide. 7,62,87
Terpenes, chlorinated 1,4,8
Tetrachloroethane 12 8
Tetrachloroethylene when in Schedule 5 or 6. 12,16 1,4,8,11
Tetrahydrozoline in nasal preparations for topical use. 29
Thalidomide 7,62,76
Thiourea 1,4
Toluene 1,4,8
Toluenediamine
(a) in hair dyes. 21
(b) in preparations other than hair dyes. 1,4,8
Tramazoline in nasal preparations for topical use. 29
Tretinoin
(a) for human oral use. 7,62,76
Triamcinolone when in topical preparations 64 or 68
for the treatment of mouth ulcers.
Trichloroacetic acid except when for 2 1,4
therapeutic use.
1,1,1-trichloroethane 8,9
Trichloroethylene except when for 12 1,4,5,8,9 therapeutic use.
Trichlorophenol 1,4,8
Triethanolamine 5 1,4
Triethyl phosphate 1,4,8
Trifluoromethanesulfonic acid
(a) more than 10 per cent. 1,17 1,4,8
(b) 10 per cent or less. 1,4,8
Triisopropanolamine lauryl ether sulfate 1,4,6
3,6,9-Trioxaundecanedioic acid 5 1
Tymazoline in nasal preparations for topical use. 29
Vinclozolin 46
Xylene 1,4,8
Xylometazoline in nasal preparations for topical use. 29
Zinc chloride 1,4
Zinc sulfate when in Schedule 6. 1,4
APPENDIX G
DILUTE PREPARATIONS
The requirements of this Standard do not apply to a poison listed in Column 1 of this Appendix at a concentration not more than that specified in Column 2 in respect of that poison.
Column 1 Column 2
Poison Concentration
(quantity per litre
or kilogram)
ACETYLCHOLINE 1 mg
ALDOSTERONE 10 micrograms
ANTIMONY COMPOUNDS 1 mg
APOMORPHINE 1 mg
ARSENIC 1 mg
ATROPA BELLADONNA (belladonna) 300 micrograms
ATROPINE 300 micrograms
CANTHARIDIN 10 micrograms
CHLORINE 5 mg
CROTON TIGLIUM (croton oil) 1 mg
DIOXANE 100 mg
ERYSIMUM spp. 1 mg
FOLLICLE-STIMULATING HORMONE 100 micrograms
GELSEMIUM SEMPERVIRENS 1 mg
GLUCAGON 100 micrograms
GLYCERYL TRINITRATE 100 micrograms
GROWTH HORMONE 10 micrograms
HALOPERIDOL 1 mg
HYDROCYANIC ACID 1 microgram
HYOSCINE 300 micrograms
HYOSCYAMINE 300 micrograms
HYOSCYAMUS NIGER 300 micrograms
HYPOTHALAMIC RELEASING FACTORS 10 micrograms
INDOMETHACIN 1 mg
MERCURY 1 mg
METHYLMERCURY 300 micrograms
NAPHTHALENE 1 mg
NERIUM OLEANDER 1 mg
OESTRADIOL 10 micrograms
OESTRONE 100 micrograms
OXYTOCIN 1 microgram
PHOSPHORUS 1 mg
PODOPHYLLUM RESIN (podophyllin) 1 mg
PROGESTERONE 1 mg
PROPRANOLOL 1 mg
SELENIUM 100 micrograms
STROPHANTHUS spp. 1 mg
STRYCHNINE 1 mg
TESTOSTERONE 1 mg
THYROXINE 10 micrograms
APPENDIX H
SCHEDULE 3 POISONS PERMITTED TO BE ADVERTISED
Butoconazole.
Clotrimazole.
Diclofenac.
Dimenhydrinate for the prevention and relief of motion sickness.
Diphenoxylate.
Econazole.
Fluconazole.
Hydrocortisone.
Miconazole.
Nystatin.
APPENDIX I
UNIFORM PAINT STANDARD
This Appendix provides regulations for adoption by the States and Territories.
1. A person must not manufacture, sell, supply or use a First Schedule Paint for application to:
(1) a roof or any surface to be used for the collection or storage of potable water; or
(2) furniture; or
(3) any fence, wall, post, gate or building (interior or exterior) other than a building which is used exclusively for industrial purposes or mining or any oil terminal; or
(4) any premises used for the manufacture, processing, preparation, packing or serving of products intended for human or animal consumption.
2. A person must not manufacture, sell, supply or use a Third Schedule paint.
3. A person must not manufacture, sell, supply or use a paint for application to toys unless the paint complies with the specification for coating materials contained in Australian/New Zealand Standard AS/NZS ISO 8124.3:2012 entitled Safety of toys Part 3: Migration of certain elements (ISO 8124-03:2010, MOD).
4. A person must not manufacture, sell, supply, or use a paint containing a pesticide except a fungicide, algicide, bactericide or antifouling agent.
The First Schedule
The proportion of a substance for the purposes of this Schedule is calculated as a percentage of the element present in the non-volatile content of the paint.
ANTIMONY or antimony compounds other than more than 5 per cent
antimony titanate pigments
BARIUM salts except barium sulfate or barium metaborate more than 5 per cent
CADMIUM or cadmium compounds more than 0.1 per cent
CHROMIUM as chromates of ammonia, barium, potassium, more than 5 per cent
sodium, strontium or zinc
SELENIUM or selenium compounds more than 0.1 per cent
The Second Schedule
CHROMIUM as chromates of ammonia, more than 5 per cent
barium, calcium, iron, potassium, sodium,
strontium or zinc
DICHLOROMETHANE (methylene chloride) more than 5 per cent by wt
ETHYLENE GLYCOL MONOALKYL ETHERS and their acetates more than 10 per cent by vol
HEXYLOXYETHANOL more than 10 per cent by vol
TOLUENE more than 50 per cent by vol
XYLENE more than 50 per cent by vol
The Third Schedule
The proportion of a substance for the purposes of this Schedule is calculated as a percentage of the element present in the non-volatile content of the paint.
LEAD or lead compounds more than 0.1 per cent
APPENDIX J
CONDITIONS FOR AVAILABILITY AND USE OF SCHEDULE 7 POISONS
CONDITIONS FOR AVAILABILITY AND USE
The following controls are recommended for poisons only when included in Schedule 7. These conditions for availability and use may be implemented through poisons controls or other State or Territory legislation.
1. Not to be available except to authorised or licensed persons.
2. Not to be used in printing inks.
3. Not to be used except by or in accordance with the directions of accredited government vermin control officers.
4. Not to be used in industries which handle, process or store foods, animal feeds or packaging materials.
APPENDIX J
A poison listed in this Appendix is to be available only in accordance with the conditions specified beside it in the “Conditions” column. The conditions apply only when the poison is included in Schedule 7.
POISONS CONDITIONS
Abamectin 1
Acibenzolar-s-methyl 1
Acrolein 1
Acrylonitrile 1
Alachlor 1
Allyl alcohol 1
4-Aminopyridine 1
Arprinocid 1
Arsenic 1
Azocyclotin 1
Benzene 1
Bifluorides (including ammonium, potassium and sodium salts) 1
(see Part 2, Labels and Containers, subparagraph 14(2))
Alprazolam
Amisulpride
Amitriptyline
Amylobarbitone
Aripiprazole
ASENAPINE
Azatadine
Baclofen
Benztropine
Bromazepam
Brompheniramine
Buclizine
Buprenorphine
Butobarbitone
Cetirizine
Chloral hydrate
Chlordiazepoxide
Chlormethiazole
Chlorpheniramine
Chlorpromazine
Clemastine
Clomipramine
Clonazepam
Clonidine
Clorazepate
Clozapine
Codeine except when included in Schedule 2 or 3.
Cyclizine
Cyclobarbitone
Cycloserine
Cyproheptadine
Cysteamine
Dantrolene
Desipramine
Dexchlorpheniramine
Dextromoramide
Dextropropoxyphene
Diazepam
Difenoxin
Dihydrocodeine
Dimenhydrinate
Dimethindene
Diphenhydramine
Diphenoxylate
Diphenylpyraline
Dothiepin
Doxepin
Doxylamine
Dronabinol (delta-9-tetrahydrocannabinol)
Droperidol
Duloxetine
Ethylmorphine
Fenfluramine
Flunitrazepam
Flupenthixol
Fluphenazine
Flurazepam
Gabapentin
Gemcitabine
Glutethimide
Haloperidol
Hydrocodone
Hydromorphone
Hydroxyzine
Imipramine
Lamotrigine
Levetiracetam
Levocabastine
Lorazepam
LURASIDONE.
Mazindol
Mebhydrolin
Meclozine
Medazepam
Meprobamate
Mepyramine
Methadone
Methdilazine
Methocarbamol
Methylphenobarbitone
Mianserin
Mirtazapine
Morphine
NABIXIMOLS .
Nalbuphine
Nitrazepam
Normethadone
Nortriptyline
Olanzapine
Opium in any form except the alkaloids noscapine and papaverine.
Oxazepam
Oxycodone
Paliperidone
Papaveretum
Pentazocine
Pentobarbitone
PERAMPANEL
Pericyazine
Perphenazine
Pethidine
Phenelzine
Pheniramine
Phenobarbitone
Phenoperidine
Phenyltoloxamine
Pholcodine
Pimozide
Pizotifen
Prazepam
Pregabalin
Prochlorperazine
Promazine
Promethazine
Protriptyline
Quetiapine
Quinalbarbitone
RETIGABINE
Risperidone
Rotigotine
RUPATADINE
Secbutobarbitone
TAPENTADOL
Temazepam
Thenyldiamine
Thiethylperazine
Thiopropazate
Thioridazine
Thiothixene
Tramadol
Tranylcypromine
Trifluoperazine
Trimeprazine
Trimipramine
Triprolidine
Ziprasidone
Zolpidem
Zonisamide
Zopiclone
APPENDIX L
REQUIREMENTS FOR DISPENSING LABELS FOR
HUMAN AND VETERINARY MEDICINES
GENERAL REQUIREMENTS FOR DISPENSING LABELS
(see Part 2, Labels and Containers, subparagraph 14(1))
(1) All details, words and other required information on a label on a container of a substance for therapeutic use must be in the English language in letters at least 1.5 millimetres in height.
(2) All symbols, numbers and words on a label must be in durable characters.
(3) The label on a container of a substance for therapeutic use must contain the following details:
(a) the name, address and telephone number of the dispenser supplying the substance;
(b) the approved name of the substance and/or its proprietary name (unless it is a preparation compounded in accordance with the dispenser’s own formula);
(c) adequate directions for use;
(d) the strength and form of the substance;
(e) the total quantity of the goods in the container;
(f) the words “KEEP OUT OF REACH OF CHILDREN” in red on a white background;
(g) if the substance is intended for external use only, the word “POISON”, or the words “FOR EXTERNAL USE ONLY”, in red on a white background;
(h) if the substance is a medicine, the name of the person for whom it was dispensed; and
(i) if the substance is a veterinary chemical, the species of animal, the name of the animal’s owner and the words “FOR ANIMAL TREATMENT ONLY”.
(4) The label on a container of a medicine or veterinary chemical that is supplied on prescription must also include:
(a) the prescription reference number;
(b) the date on which the prescription was supplied (unless that date is clear from the prescription reference number); and
(c) the directions for use set out in the prescription.
APPENDIX L
ADDITIONAL LABELLING REQUIREMENTS FOR CERTAIN HUMAN MEDICINES
(see Part 2, Labels and Containers, subparagraph 14(2))
Medicines required to be labelled with certain warning statements A substance listed in Column 1 of the following table must be labelled with the warning statement in Appendix F, Part 1, as specified opposite in Column 2.